Study of the Involvement of 15q11 - q13 Chromosome Region and CYFIP1 Gene in Autism. Attempt a Genotype-phenotype Correlation
Primary Purpose
Autistic Disorder
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Genetic test
Sponsored by
About this trial
This is an interventional diagnostic trial for Autistic Disorder
Eligibility Criteria
Inclusion Criteria:
- Subject unadopted 4 to 18 years
- Subject completing the autism spectrum disorder criteria development by diagnostic grid ICD10 recognized by the international community child psychiatry. The ADI-R test is always associated.
- Subject has at least one of the following abnormalities:
Mental retardation, Anomaly morphological examination (abnormal weight and height growth and / or head circumference, abnormal ends, dysmorphic ...) Malformation (s) visceral (s) Behavioural disorders other than autistic disorder (aggression, sleep disorders ...) Abnormal neurological examination and brain imaging, Family history of autism and / or mental retardation.
- Parents of the subject and topics affiliated to a social security scheme
Exclusion Criteria:
- Etiologie de la pathologie autistique connue (Syndrome de Rett, Xfra…)
- Absence de consentement éclairé des patients et des représentants de l'autorité parentale
- Parents sous tutelle ou curatelle
Sites / Locations
- CHU de Nice
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Autistic disorder
Arm Description
Children over 4 years with an autistic disorder of unknown etiology with the techniques currently available and accessible in routine diagnostics.
Outcomes
Primary Outcome Measures
presence or absence of abnormality in 15q11q13 gene
Testing a candidate gene in a chromosomal region known to be involved in autism
Secondary Outcome Measures
phenotype
Syndromic or specific behavioral phenotypes corresponding to the identified molecular abnormalities
Full Information
NCT ID
NCT02862340
First Posted
July 21, 2016
Last Updated
August 8, 2016
Sponsor
Centre Hospitalier Universitaire de Nice
1. Study Identification
Unique Protocol Identification Number
NCT02862340
Brief Title
Study of the Involvement of 15q11 - q13 Chromosome Region and CYFIP1 Gene in Autism. Attempt a Genotype-phenotype Correlation
Official Title
Study of the Involvement of 15q11 - q13 Chromosome Region and CYFIP1 Gene in Autism. Attempt a Genotype-phenotype Correlation
Study Type
Interventional
2. Study Status
Record Verification Date
August 2016
Overall Recruitment Status
Completed
Study Start Date
January 2008 (undefined)
Primary Completion Date
January 2008 (Actual)
Study Completion Date
February 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Nice
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Autism, ranked among the '' pervasive developmental disorders' (ASD), is characterized by disturbances in the areas of reciprocal social interaction, communication and behavior, interests and activities restricted, repetitive. Various studies indicate that autistic disorder is subjected to a genetic predisposition, most likely polygenic and heterogeneous. However, no major gene responsible for this disorder has yet been identified. Given the link between the Fragile X syndrome (the most common form of mental retardation (MR) hereditary) and autistic behavior, it seems interesting to look, also, a possible link to the molecular level. Among the proteins interacting with FMRP (absent protein in fragile X patients), the investigators were interested to CYFIP1, protein encoded by the gene CYFIP1 appears to be a good candidate gene involved in the RM and autism by its chromosomal position and function. As FMR1, CYFIP1 is expressed in the brain cortex, hippocampus and Purkinje cells of the cerebellum. This protein co-localizes and interacts with Rac and FMRP, which are both involved in neurogenesis and cognitive development. In humans, the gene encoding CYFIP1 is located in the 15q11-q13. Now, the only autosomal abnormalities most frequently observed in autism are those involving the proximal 15q region, including duplications or 15q11-q13 triplications interstitial, of maternal origin.
These data suggest that an / or more autism genes responsible are probably present in the 15q11-q13 chromosomal region, although no gene has yet been identified. Thus, the study of the role of CYFIP1 gene in patients with autism spectrum disorders would most likely contributory.
The investigators wish to study the involvement of the 15q11-q13 chromosomal region and CYFIP1 gene in autistic disorder in a hundred patients from the Autism Resource Centre (ARC) Nice PACA antenna, over a two year period.
The diagnosis and assessment report of children likely to be included in this study will be conducted at ARC Nice. Balance sheets are made according to the recommendations of the High Authority of Health for diagnosis of infantile autism and PDD. These children are then sent to the Genetic Consultation Nice Hospital where an analysis of the background and a specific morphological examination will be realized..
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Autistic Disorder
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Autistic disorder
Arm Type
Other
Arm Description
Children over 4 years with an autistic disorder of unknown etiology with the techniques currently available and accessible in routine diagnostics.
Intervention Type
Genetic
Intervention Name(s)
Genetic test
Primary Outcome Measure Information:
Title
presence or absence of abnormality in 15q11q13 gene
Description
Testing a candidate gene in a chromosomal region known to be involved in autism
Time Frame
At the inclusion
Secondary Outcome Measure Information:
Title
phenotype
Description
Syndromic or specific behavioral phenotypes corresponding to the identified molecular abnormalities
Time Frame
At the inclusion
10. Eligibility
Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subject unadopted 4 to 18 years
Subject completing the autism spectrum disorder criteria development by diagnostic grid ICD10 recognized by the international community child psychiatry. The ADI-R test is always associated.
Subject has at least one of the following abnormalities:
Mental retardation, Anomaly morphological examination (abnormal weight and height growth and / or head circumference, abnormal ends, dysmorphic ...) Malformation (s) visceral (s) Behavioural disorders other than autistic disorder (aggression, sleep disorders ...) Abnormal neurological examination and brain imaging, Family history of autism and / or mental retardation.
- Parents of the subject and topics affiliated to a social security scheme
Exclusion Criteria:
Etiologie de la pathologie autistique connue (Syndrome de Rett, Xfra…)
Absence de consentement éclairé des patients et des représentants de l'autorité parentale
Parents sous tutelle ou curatelle
Facility Information:
Facility Name
CHU de Nice
City
Nice
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Study of the Involvement of 15q11 - q13 Chromosome Region and CYFIP1 Gene in Autism. Attempt a Genotype-phenotype Correlation
We'll reach out to this number within 24 hrs